EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 31-May-2026 16:15 ET (31-May-2026 20:15 GMT/UTC)

Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT), takes office as president of the SNMMI Technologist Section

Society of Nuclear Medicine and Molecular Imaging
Business Announcement

Shannon Youngblood, EdD, MSRS, CNMT, RT(CT)(ARRT), has been elected president of the Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS). The new slate of officers was introduced during the SNMMI's 2026 Annual Meeting, held May 30 - June 2 in Los Angeles.

Meeting: Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting

Sara L. Johnson, EdD, named president-elect of the SNMMI Technologist Section

Society of Nuclear Medicine and Molecular Imaging
Business Announcement

Sara L. Johnson, EdD, MAEd, BS, CNMT, NMTCB(RS), RT(N)(CT)(ARRT), FSNMMI-TS, has been named president-elect of the SNMMI Technologist Section (SNMMI-TS). Johnson is a PET/CT technologist at Florida Cancer Specialists in Brandon, Florida, and a didactic instructor at Gurnick Academy of Medical Arts. SNMMI introduced its 2026-27 officers at its 2026 Annual Meeting, held May 30 - June 2 in Los Angeles.

Meeting: Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting

Richard E. Carson, Ph.D., receives SNMMI 2026 Paul C. Aebersold Award for Outstanding Achievement in Basic Nuclear Medicine Science

Society of Nuclear Medicine and Molecular Imaging
Grant and Award Announcement

Richard E. Carson, PhD, has been named the 2026 recipient of the prestigious Paul C. Aebersold Award. Carson is professor of Biomedical Engineering and of Radiology and Biomedical Imaging at Yale University in New Haven, Connecticut, as well as emeritus director of the Yale PET Center. The award was announced by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) during its 2026 Annual Meeting.

Meeting: Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting

Irène Buvat, Ph.D., receives SNMMI 2026 George Charles de Hevesy Nuclear Pioneer Award

Society of Nuclear Medicine and Molecular Imaging
Grant and Award Announcement

Irène Buvat, PhD, a leading expert in molecular imaging quantification, is the recipient of SNMMI's George Charles de Hevesy Nuclear Pioneer Award, presented at the society's 2026 Annual Meeting, May 30 through June 2 in Los Angeles. Buvat's work has fundamentally changed how the field measures, models, and interprets molecular imaging data, laying the scientific groundwork for more accurate diagnosis and treatment of cancer.

Meeting: Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting

Institutional special needs plans and end-of-life outcomes for nursing home residents with dementia

JAMA Network
Peer-Reviewed Publication

About The Study: In this retrospective cohort study, Institutional Special Needs Plan (I-SNP) enrollment was associated with significantly fewer hospitalizations for nursing home residents with dementia at the end of life, with effect sizes larger for UnitedHealthcare (UHC) vs non-UHC I-SNPs. Plan maturity and volume are likely important factors impacting success.

Journal: JAMA Health Forum

Regulatory definitions and classification of biosimilar medications across the 6 regions of the World Health Organization

JAMA Network
Peer-Reviewed Publication

About The Study: This scoping review provides a detailed comparison of biosimilar regulatory guidelines across all World Health Organization regions and identified similarities and differences that may limit the transferability of data between and among countries. These barriers can potentially affect medication availability, price, access, and reimbursement of biosimilars.

Journal: JAMA Health Forum

Major gaps in online info for patients about AI and cancer

University of Pennsylvania School of Medicine
Reports and Proceedings

A new analysis shows that online information about AI and cancer is limited, low quality, difficult to read, and frequently omits risks of AI use.

Meeting: ASCO Annual Meeting 2026

Breakthrough in cancer immunotherapy: Dresden researchers present promising therapy for advanced solid tumors

Technische Universität Dresden
Peer-Reviewed Publication

A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) in Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors. The results show overall good tolerability and clear signs of effectiveness of this novel immunotherapy. They are published in the renowned scientific journal Nature Medicine.

Journal: Nature Medicine

Cancer diagnostic delay rates associated with a population-based screening trial evaluating a cell-free DNA multicancer early detection test

JAMA Network
Peer-Reviewed Publication

About The Study: Regional participation in a population-based multicancer early detection (MCED) screening trial was associated with a modest increase in diagnostic delay rates for patients referred for suspected head and neck, lung, and upper gastrointestinal cancers. This increase is unlikely to have materially affected interpretation of the MCED screening trial primary findings. Future trials of population-based screening interventions likely to affect demand for limited health care resources should consider monitoring for system-level spillover effects.

Journal: JAMA

1
2
3